Webinar title: Liquid-based Detection of Copy Number Variations (CNVs) in Cancer
Date: Wednesday, April 6, 2021
Duration: 32 minutes
The liquid biopsy landscape (CNVs) is changing rapidly. Predicine is advancing the clinical utility of liquid biopsy more broadly across the continuum of cancer care. We are innovating our liquid biopsy technology to detect a range of genomic signatures that will impact clinical care in the future.
View other webinars from Predcine’s webinar series: